Swiss pharmaceutical company Novartis has won approval from the U.S. Food and Drug Administration to begin a clinical trial on the efficacy of hydroxychloroquine in treating hospitalized COVID-19 patients. The trial will begin immediately in more than a dozen sites across the U.S. and will include about 440 patients. “We recognize the importance of answering … Continue reading Swiss Pharm Co Wins FDA Approval To Start Hydroxychloroquine Clinical Trials In U.S.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed